Thursday, July 2, 2015

Vertex's $259,000 Cystic Fibrosis Drug Approved

Vertex’s cystic-fibrosis drug Orkambi, which treats the most common mutation of the disease, received U.S. regulatory approval on Thursday.

from WSJ.com: US Business http://ift.tt/1T8NlVY
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)